Astrea Bioseparations (“Astrea Bio”), a leading provider of high-quality bioseparation and purification technologies that help to improve patient outcomes with safer and more effective production of therapeutics, announces the expansion of its manufacturing and warehousing capabilities in the US. The increased capacity reflects growing demand for the Company’s chromatography solutions in North American markets.
The new fertility technology IVG is supposed to change everything. Don’t count on it yet
There are times when a new medical technology is thrust into the public spotlight because it seems like it might solve what we thought was
October 2, 2023